Enliven Therapeutics ELVN
NASDAQ ELVN
$45.91 -0.60 (-1.29%)
As of: Sep 30, 2026 · 10:25 AM EDT

Enliven Therapeutics (ELVN) Total Liabilities (2019 - 2026)

Updated

Enliven Therapeutics (ELVN) recorded Total Liabilities of $15.07 million in Q2 2026, down 2.2% from $15.42 million a year earlier but up 31.2% from the prior quarter.

Analysis

Enliven Therapeutics (ELVN) Total Liabilities (2019 - 2026) Analysis & Trends

At the end of FY2025, Enliven Therapeutics reported Total Liabilities of $16.57 million, up 4.1% from FY2024.

  • Annual Total Liabilities has a five-year compound annual growth rate of 20.9% (FY2020 to FY2025).
  • Across earlier years, Total Liabilities came in at $15.92 million in FY2024 (-38.7%), $25.96 million in FY2023 (-83.8%), $160.12 million in FY2022 (+17.3%) and $136.53 million in FY2021.
  • Quarterly Total Liabilities has ranged from $7.65 million in Q3 2021 to $160.12 million in Q4 2022 over the past five years.
  • On a year-over-year basis, Total Liabilities rose in two of the last eight quarters, with an average decline of 13.1%.
  • Peak year-over-year performance for Total Liabilities in the last five years was growth of 132.6% in Q2 2024, against a decline of 92.3% in Q2 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $11.49 million (Q1 2026), $16.57 million (Q4 2025) and $14.75 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 116.09 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 141.05 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 87.82 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 80.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 65.46 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 83.95 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 37.53 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 115.64 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 7.18 Bn
10 Enliven Therapeutics 3.37 Bn 3.37 Bn - 15.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.07 Mn
Mar 31, 2026 11.49 Mn
Dec 31, 2025 16.57 Mn
Sep 30, 2025 14.75 Mn
Jun 30, 2025 15.42 Mn
Mar 31, 2025 14.27 Mn
Dec 31, 2024 15.92 Mn
Sep 30, 2024 17.03 Mn
Jun 30, 2024 22.11 Mn
Mar 31, 2024 25.07 Mn
Dec 31, 2023 25.96 Mn
Sep 30, 2023 12.29 Mn
Jun 30, 2023 9.51 Mn
Mar 31, 2023 11.45 Mn
Dec 31, 2022 160.12 Mn
Sep 30, 2022 127.20 Mn
Jun 30, 2022 123.38 Mn
Mar 31, 2022 132.21 Mn
Dec 31, 2021 136.53 Mn
Sep 30, 2021 7.65 Mn
API Access

Enliven Therapeutics Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=ELVN&period=max&api_key=YOUR_API_KEY